educational events - emeunet 2016...eular 2016 see you in london! russka shumnalieva, richard...

THE EMERGING EULAR NETWORKEDITION MAY-JUNE 2016

EULAR 2016 LONDON

Oral presentations and posters

“The young rheumatologist” sessions

Activities and get together

Mentor/Mentee meetings

The EULAR-EMEUNET Ambassador

Programme

3rd Country Liaison Meeting

EDUCATIONAL EVENTS

EULAR DO NOT MISS

Hilfslinien anzeigen über Menu:

Ursprungsform

im Menü über:

Start | Absatz | Listenebene

DIRECTORY

MAY-JUNE16

EDITORIAL

PAGE 2

Dear young rheumatologistsand researchers inrheumatology,

We are happy to present you a new issue

of EMEUNEWS about the Do-Not-Miss

Topics of this year´s EULAR annual

meeting.

The EULAR congress is the largest

scientific event in Rheumatology. As it is

now approaching, we provide a selection

of oral presentations and posters that we

consider to be noteworthy. Albeit this is a

limited way of looking at the numerous

scientific releases at EULAR 2016, it

might provide an overview of hot topics in

each field of Rheumatology.

This current Newsletter also contains

details about the “Young Rheumatologist”

sessions and other events organized

during the Congress.

Do not forget to visit our EMEUNET

booth to get additional info and meet up

with other young rheumatologists.

EMEUNET is now active in social media

hubs such as Facebook and Twitter,

while maintaining the traditional website

and the important physical (and

personal) presence at major

Rheumatology scientific events.

If this is your first contact with

EMEUNET, we invite you to explore

more and join us. If you are already part

of our community, we kindly remind you

that sharing is caring. Spread the word

about our activities and work, and help us

reach more young rheumatologists and

researchers.

We hope you enjoy reading this

Newsletter. We always welcome

feedback, comments, suggestions and

contributions.

We wish you a prolific and successful

EULAR 2016

See you in London!

Russka Shumnalieva, Richard Conway,

Francesco Carubbi and Alessia Alunno

on behalf of the Newsletter Subgroup

EULAR 2016: ORAL PRESENTATIONS & POSTERS 4

Basic Research I

Basic Research II

RA I

RA II

RA III

Psoriatic Arthritis

Axial Spondyloarthritis

SLE and APS

Other connective tissue diseases

Imaging

Crystal Arthropathies

Osteoarthritis & Osteoporosis

Pediatric Rheumatology

THE YOUNG RHEUMATOLOGIST SESSIONS 16

EMEUNET EVENTS AT EULAR 2016 20

MENTOR MENTEE MEETINGS 21

EULAR EMEUNET AMBASSADOR PROGRAMME 22

3RD COUNTRY LIAISONS MEETING 23

EDUCATIONAL EVENTS 24

This year due to EULAR embargo rules, only

titles and authors of abstracts have been

published ahead of the Congress. Therefore,

please note that the following selection has

been performed based ONLY on abstract titles.

We appreciate your understanding.


Folie in Ursprungsform

Wechsel der Textebene/Formatierungen

Start

PAGE 3

Anna Olewicz-Gawlik, MD PhD is a specialist in clinical immunology and a postdoctoral research fellow at the Department of

Rheumatology and Clinical Immunology at Poznan University of Medical Sciences. Her professional interests focus on

systemic sclerosis, Sjögren’s syndrome and immunology.

BASIC RESEARCH I

Genetics, cartilage/synovium, osteoimmunology, animal models

Anna Olewicz-Gawlik

ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON

MAY-JUNE16

Type, n° Date, time Session Room Author Title

OP0068

Thursday

09.06.2016

10:20

Cartilage, bone,

synovium

Capital Suite

06

van den Bosch M.

(Netherlands,

United States)

WISP1 INDUCES PATHOLOGY

IN EXPERIMENTAL

OSTEOARTHRITIS AND

PREDICTS DISEASE

PROGRESSION IN EARLY

OSTEOARTHRITIS PATIENTS.

OP0069

Thursday

09.06.2016

10:30

Cartilage, bone,

synovium

Capital Suite

06

Hood J.

(United States)

DISCOVERY OF A SMALL

MOLECULE INHIBITOR OF THE

WNT PATHWAY (SM04690) AS

A POTENTIAL DISEASE

MODIFYING TREATMENT FOR

KNEE OSTEOARTHRITIS.

OP0073

Thursday

09.06.2016

11:10

Cell-cell

interaction in joint

inflammation

Capital Suite

06

Schoenfeld C.

(Germany)

RNA-SEQ BASED

IDENTIFICATION OF FACTORS

INVOLVED IN KNEE JOINT

REGENERATION AFTER

INDUCED OSTEOARTHRITIS IN

NOTOPHTALMUS

VIRIDESCENS.

SP0177

Saturday

11.06.2016

08:35

Cell-cell

interaction in joint

inflammation

Capital Suite

14

Brahn E.

(United States)

INHIBITORY PATHWAYS OF

SYNOVIAL ANGIOGENESIS.

POSTER

SAT0009

Saturday

11.06.2016

10:20

Poster Tour:

Genomics, genetic

basis of disease

and HLA/T cell

recognition

Poster

Area

Nair N.

(United Kingdom,

Ireland)

INVESTIGATION OF

DIFFERENTIAL METHYLATION

AS A POTENTIAL BIOMARKER

OF METHOTREXATE

RESPONSE IN PATIENTS WITH

RHEUMATOID ARTHRITIS.

SP0194

Saturday

11.06.2016

12:25

Bone and heart:

common

molecular

mechanisms in

osteoporosis and

atherosclerosis

Capital Suite

11

Geusens P.

(Belgium)

DO BONE EROSIONS RESULT

FROM LOCAL SYNOVITIS OR

BONE MARROW EDEMA?

OP0310

Saturday

11.06.2016

13:15

Bone and heart:

common

molecular

mechanisms in

osteoporosis and

atherosclerosis

Capital Suite

11

Barbarroja N.

(Spain)

ASSOCIATION OF NEUTROPHIL

EXTRACELLULAR TRAPS WITH

ATHEROSCLEROSIS IN





Start

PAGE 4

Katrin Thorarinsdottir, MD PhD candidate is a rheumatologist at the Department of Rheumatology at Sahlgrenska University

Hospital, Gothenburg, Sweden. Her research activity mainly focuses on B cells and rheumatoid arthritis.

BASIC RESEARCH II

Immunity, immunology

Katrin Thorarinsdottir


MAY-JUNE16


OP0022

Wednesday

08.06.2016

18:05

Nanomedicine in

rheumatology

Capital suite

14

Codullo V.

(Italy)

TARGETING FIBROBLASTOID-LIKE

CELLS BY DRUG LOAD

ENGINEERED GOLD

NANOPARTICLES AS A NOVEL

APPROACH TO ILD-SSC

TREATMENT.

OP0026

Thursday

09.06.2016

09:20

Plasma cells as

key players and

therapeutic

target in

rheumatic

diseases

Capital suite

11

Scherer H.

(Netherlands)

SYNOVIAL FLUID MONONUCLEAR

CELLS PROVIDE AN ENVIRONMENT

FOR LONG-TERM SURVIVAL OF

ANTIBODY SECRETING CELLS AND

PROMOTE THE SPONTANEOUS

PRODUCTION OF ANTI-

CITRULLINATED PROTEIN

ANTIBODIES.

POSTER

THU0001

Thursday

09.06.2016

11:45

Poster Tour:

Immunity in

rheumatic

diseases

Poster

Area

Sacre K.

(France)

TERTIARY LYMPHOID ORGANS IN

TAKAYASU ARTERITIS: ARE

LOCALLY MATURED B CELLS

INVOLVED IN THE PATHOGENESIS?

OP0148

Thursday

09.06.2016

16:50

How cell death

shapes

immunity and

tolerance

Capital Suite

11

Chirivi R.

(Netherlands)

FIRST IN CLASS THERAPEUTIC

ACPA REDUCES INFLAMMATION BY

INHIBITION OF NETOSIS.

OP0206

Friday

10.06.2016

11:30

Novel insights

into B and T cell

immunity in

rheumatic

diseases

S20Renoux F.

(France)

FRA2 IS PLAYING A KEY ROLE IN

THE CONTROL OF TREG

DEVELOPMENT AND

AUTOIMMUNITY.

POSTER

FRI0001

Friday

10.06.2016

11:45

Poster Tour:

Time for some

fun with

molecules

Poster

Area

Cavalli G.

(Italy)

TREATING EXPERIMENTAL

ARTHRITIS WITH THE INNATE

IMMUNE INHIBITOR IL-37 REDUCES

JOINT AND SYSTEMIC

INFLAMMATION.

POSTER

SAT0021

Saturday

11.06.2016

10:15

Poster Tour:

Innate immune

cells coming to

play

Poster

Area

Wohlfahrt T.

(Germany)

TYPE 2 INNATE LYMPHOID CELLS

ARE RAPIDLY AND PERSISTENTLY

RECRUITED IN EXPERIMENTAL

FIBROSIS AND THEIR COUNTS

CORRELATE WITH THE SEVERITY

OF SKIN AND LUNG FIBROSIS IN

SYSTEMIC SCLEROSIS.

POSTER

SAT0027

Saturday

11.06.2016

10:15

Poster Tour:

Innate immune

cells coming to

play

Poster

Area

Young N.

(United States)

INHIBITION OF TLR7 AND TLR8

SIGNALING BY ANTAGONIZING

MICRO-RNA DERIVED FROM

EXTRACELLULAR VESICLES

SUPPRESSES INFLAMMATION IN A

NOVEL HUMAN-MOUSE CHIMERIC

MODEL OF LUPUS.




Start

PAGE 5

RA I

Epidemiology, clinics and non biologics

Marlies van der Goes


MAY-JUNE16


OP0177

Thursday

09.06.2016

10:40

Prognosis and

outcome in RAHall B

Haavardsholm EA.

(Norway)

ULTRASOUND IN THE

MANAGEMENT OF RHEUMATOID

ARTHRITIS: RESULTS FROM THE

RANDOMIZED CONTROLLED

ARCTIC TRIAL.

POSTER

THU0078

Thursday

09.06.2016

11:45

Poster Tour:

Comorbidities

update 2016 part 1

Poster

Area

Humphreys JH.

(United Kingdom)

MODERATE ALCOHOL

CONSUMPTION IS NOT

ASSOCIATED WITH SERUM

LIVER ABNORMALITIES IN

PATIENTS WITH RHEUMATOID

ARTHRITIS TAKING

METHOTREXATE: DATA FROM

THE CLINICAL PRACTICE

RESEARCH DATABASE (CPRD).

POSTER

THU0032

Thursday

09.06.2016

11:45

Poster Tour:

Prognosis and

outcome in RA

Poster

Area

Nieuwenhuis WP.

(Netherlands)

DIAGNOSTIC ACCURACY OF

HAND AND FOOT MRI FOR

EARLY RHEUMATOID ARTHRITIS.

OP0141

Thursday

09.06.2016

16:35

Optimization of

MTX in RA

treatment

Hall DFlipo RM.

(France)

WHICH STRATEGIES IN

RHEUMATOID ARTHRITIS

PATIENTS WITH INADEQUATE

RESPONSE TO METHOTREXATE

MONOTHERAPY: THE STRATEGE

STUDY.

OP0173

Friday

10.06.2016

10:40

Epidemiology in

RMDsHall C

Bartlett SJ.

(Canada)

HOW MUCH OF A BARRIER IS

EXCESS WEIGHT AND SMOKING

FOR ACHIEVING SUSTAINED

REMISSION IN EARY RA?

RESULTS FROM THE CANADIAN

EARLY ARTHRITIS COHORT.

OP0259

Friday

10.06.2016

11:00

ComorbiditiesCapital Suite

11

Curtis JR.

(United States)

IMPACT OF SUSTAINED

REMISSION ON RISK INFECTION

IN PATIENTS WITH RHEUMATOID

ARTHRITIS ENROLLED IN A US

REGISTRY.

POSTER

FRI0155

Friday

10.06.2016

11:00

Poster Tour: RA

treatment,

predictors tapering

and biosimilars

Poster

Area

Sigaux J.

(France)

FIFTY PERCENT OF PATIENTS

WHO TAPERED TNF-BLOCKERS

WHILE IN STABLE REMISSION

ARE ABLE TO MAINTAIN A

TAPERED REGIMEN AT 3 YEAR:

LONG TERM FOLLOW-UP

EXTENSION OF THE STRASS

TRIAL.

Marlies van der Goes, MD PhD is a rheumatologist in training at the Department of Rheumatology & Clinical Immunology of

the University Medical Center Utrecht in the Netherlands. Her research focuses on rheumatoid arthritis and glucocorticoid

therapy. She is the EMEUNET Country Liaison for the Netherlands.




Start

PAGE 6

Meghna Jani, MRCP MSc PhD in an NIHR clinical lecturer at the ARUK Centre for Epidemiology and a rheumatology

specialy trainee in Manchester, UK. Her main interests are biomarkers of treatment response, immunogenicity in response to

biologic drugs, drug safety and pharmacoepidemiology.

RA II

Biological therapies: anti-TNF

Meghna Jani


MAY-JUNE16


OP

Wednesday

08.06.2016

17:00

Clinical

relevance of

immunogenicity

and therapeutic

drug monitoring

Hall DKvien TK.

(Norway)

BIOSIMILARS: OBSERVATIONAL

REAL-LIFE DATA.

OP0175

Thursday

09.06.2016

10:20

Prognosis and

outcome in RAHall B

Bouman C.

(Netherlands)

RADIOGRAPHIC PROGRESSION IN

RHEUMATOID ARTHRITIS PATIENTS

TAPERING TNFI IS PRIMARILY

DRIVEN BY MEAN DISEASE

ACTIVITY OOVER TIME, NOT SO

MUCH BY FLARING OR LOWER TNFI

EXPOSITION.

POSTER

THU0034

Thursday

09.06.2016

11:45

Poster Tour:

Prognosis and

outcome in RA

Poster

Area

Raynauld JP.

(Canada)

USE OF RITUXIMAB COMPARED TO

ANTI-TNF AGENTS AS SECOND AND

THIRD-LINE THERAPY IN PATIENTS

WITH RHEUMATOID ARTHRITIS. A 6-

YEAR FOLLOW-UP REPORT FROM

THE RHUMADATA CLINICAL

DATABASE AND REGISTRY.

OP0225

Friday

10.06.2016

10:40

Developments

in the treatment

of RA

Hall DGlintborg B.

(Denmark)

THREE MONTHS’ CLINICAL

OUTCOMES FROM A NATIONWIDE

NON-MEDICAL SWITCH FROM

ORIGINATOR TO BIOSIMILAR

INFLIXIMAB IN PATIENTS WITH

INFLAMMATORY ARTHRITIS.

RESULTS FROM THE DANBIO

REGISTRY.

POSTER

FRI0159

Friday

10.06.2016

11:45

Poster Tour: RA

treatment:

Predictors,

tapering and

biosimilars

Poster

Area

Lau A.

(Canada)

PERSISTENCE WITH BIOLOGIC

MONOTHERAPY IN COMPARISON

WITH COMBINATION THERAPY

WITH DISEASE-MODIFYING

ANTIRHEUMATIC DRUGS IN


ARTHRITIS; RESULTS FROM AN

ONTARIO RHEUMATOID ARTHRITIS

COHORT.

POSTER

FRI0154

Friday

10.06.2016

11:45

Poster Tour: RA

treatment:

Predictors,

tapering and

biosimilars

Poster

Area

Holroyd C.

(United Kingdom)

ARE THERE NEGATIVE EFFECTS

ON DISEASE ACTIVITY AND

FUNCTION ASSOCIATED WITH

FAILED ANTI-TNF DOSE

REDUCTION STRATEGIES FOR RA

PATIENTS?




Start

PAGE 7

Richard Conway, MB BCh BAO MRCPI LRCSI CCD, has completed specialist training in rheumatology and general internal

medicine and is currently a vasculitis fellow at St. Vincent’s University Hospital and University College Dublin, Ireland. His

major research interests include giant cell arteritis and meta-analysis.

RA III

Other biologics and new drugs beyond biologics

Richard Conway


MAY-JUNE16


OP0159

Thursday

09.06.2016

10:20

New pathways

to treatment

Capital Suite

13

Reddy V.

(United Kingdom)

IMPROVING B-CELL DEPLETION IN

RHEUMATOID ARTHRITIS AND SYSTEMIC

LUPUS ERYTHEMATOSUS: RESISTANCE

TO RITUXIMAB AND THE POTENTIAL OF

OBINUTUZUMAB.

OP0178

Thursday

09.06.2016

10:50

Prognosis and

outcome in RAHall B

Harrold LR.

(United States)

IMPACT OF ANTI-CYCLIC CITRULLINATED

PEPTIDE AND RHEUMATOID FACTOR

STATUS ON RESPONSE TO ABATACEPT

THERAPY: FINDINGS FROM A US

OBSERVATIONAL COHORT.

OP0182

Thursday

09.06.2016

11.30

Prognosis and

outcome in RAHall B

Gerlag D.

(Netherlands)

PREVENTION OF RHEUMATOID

ARTHRITIS BY B CELL DIRECTED

THERAPY IN THE EARLIEST PHASE OF

THE DISEASE: THE PRAIRI STUDY.

POSTER

THU0173

Thursday

09.06.2016

11:45

Poster Tour: RA

treatments - non

biological, small

molecules

Poster

Area

Kavanaugh A.

(United States)

FILGOTINIB (GLPG0634), AN ORAL JAK1

SELECTIVE INHIBITOR IS EFFECTIVE AS

MONOTHERAPY IN PATIENTS WITH

ACTIVE RHEUMATOID ARTHRITIS:

RESULTS FROM A 24-WEEK PHASE 2B

DOSE RANGING STUDY.

OP0228

Friday

10.06.2016

11:10

Developments

in the treatment

of RA

Hall DTakeuchi T.

(Japan)

BARICITINIB DOSE STEP-DOWN

FOLLOWING DISEASE CONTROL IN


ARTHRITIS.

OP0260

Friday

10.06.2016

11:10

ComobiditiesCapital Suite

11

Strangfeld A.

(Germany)

LOWER INTESTINAL PERFORATIONS ARE

MORE FREQUENT AND PRESENT

UNTYPICALLY IN PATIENTS TREATED

WITH TOCILIZUMAB COMPARED TO

OTHER BIOLOGIC OR CONVENTIONAL

SYNTHETIC DMARDS.

POSTER

FRI0199

Friday

10.06.2016

11:45

Poster Tour:

Safety and

efficacy of non-

TNFa blockers

in the treatment

of RA – I

Poster

Area

Behrens F.

(Germany)

RITUXIMAB IN COMBINATION WITH

LEFLUNOMIDE: RESULTS FROM A

MULTICENTER RANDOMIZED PLACEBO

CONTROLLED INVESTIGATOR INITIATED

CLINICAL TRIAL IN ACTIVE RHEUMATOID

ARTHRITIS (AMARA-STUDY).

POSTER

SAT0146

Saturday

11.06.2016

10:15

Poster Tour:

Safety and

efficacy of non

TNFa blockers

in the treatment

of RA – II

Poster

Area

Weinblatt M.

(United States)

EARTH EXPLORER 2, A PHASE IIB

EXPLORATORY STUDY EVALUATING

EFFICACY AND SAFETY OF

MAVRILIMUMAB, A FULLY HUMAN

GRANULOCYTE-MACROPHAGE COLONY-

STIMULATING FACTOR RECEPTOR-

ALPHA MONOCLONAL ANTIBODY, AND

THE TUMOR NECROSIS FACTOR

ANTAGONIST GOLIMUMAB IN





Start

PAGE 8

PSORIATIC ARTHRITIS

Paul Studenic


MAY-JUNE16


OP0091

Thursday

09.06.2016

11:30

SpA and PsA

clinical

Capital Suite

11

El Miedany Y.

(United Kingdom)

PSORIATIC ARTHRITIS

COMORBIDITY INDEX:

DEVELOPMENT AND VALIDATION OF

A NEW SPECIFIC TOOL FOR

CLASSIFYING PROGNOSTIC

COMORBIDITY IN PSORIATIC

ARTHRITIS PATIENTS.

OP0127

Thursday

09.06.2016

14:45

Advancements

in the imaging of

PsA

Hall DMerashli M.

(United Kingdom)

LOW FREQUENCY OF US

DETERMINED EROSIONS IN EARLY

PSORIATIC ARTHRITIS: RESULTS

FROM THE LEEDS SPARRO

COHORT.

POSTER

THU0434

Thursday

09.06.2016

All day

Poster Session:

Psoriatic arthritis

Poster

Area

Ritchlin C.

(United States)

SERIOUS INFECTIONS IN PSORIASIS

PATIENTS WITH PSORIATIC

ARTHRITIS IN THE PSORIASIS

LONGITUDINAL ASSESSMENT AND

REGISTRY STUDY.

POSTER

THU0444

Thursday

09.06.2016

All day

Poster Session:

Psoriatic arthritis

Poster

Area

Eder L.

(Canada)

SUBCLINICAL ULTRASONOGRAPHIC

ENTHESITIS IN PATIENTS WITH

PSORIASIS IS ASSOCIATED WITH

RISK MARKERS FOR PSORIATIC

ARTHRITIS.

POSTER,

THU0428

Thursday

09.06.2016

All day

Poster Session:

Psoriatic arthritis

Poster

Area

Pfeil A.

(Germany)

PSORIASIS ARTHRITIS IS

ASSOCIATED WITH PERIARTICULAR

BONE LOSS OF THE METACARPALS.

OP0108

Friday

10.06.2016

10:20

Expanding

therapeutic

options in

spondyloarthritis

Hall BGlatt S.

(United Kingdom)

BIMEKIZUMAB, A MONOCLONAL

ANTIBODY THAT INHIBITS BOTH IL-

17A AND IL-17F, PRODUCES A

PROFOUND RESPONSE IN BOTH

SKIN AND JOINTS: RESULTS OF AN

EARLY-PHASE, PROOF-OF-

CONCEPT STUDY IN PSORIATIC

ARTHRITIS.

POSTER

FRI0446

Friday,

10.06.2016

11:45

Poster Session:

Psoriatic arthritis

Poster

Area

Thaçi D.

(Germany)

TREATMENT WITH TILDRAKIZUMAB,

AN ANTI-IL-23P19 MONOCLONAL

ANTIBODY, IMPROVES HEALTH-

RELATED QUALITY OF LIFE IN

PATIENTS WITH CHRONIC PLAQUE

PSORIASIS.

Paul Studenic, MD is a medical resident and clinical research fellow at the Division of Rheumatology of the Medical

University Vienna in Austria. His main interests are outcomes assessment in RA and PsA, patient reported outcomes,

predictors of disease activity, biomarkers and elderly patients. He is currently engaged in the EMEUNET Social Media

Subgroup.




Start

PAGE 9

João Madruga Dias, MD is a rheumatology consultant at Centro Hospitalar Médio Tejo (Portugal) with a special interest in

inflammatory rheumatic diseases, pregnancy, musculoskeletal ultrasound and arthroscopy. He trained arthroscopy in Saint

Vincent’s University Hospital, University College of Dublin. He is a member of the board of the Rheumatology College of the

Portoguese Medical Association and the Portuguese representative at UEMS (European Union of Medical Specialists).

AXIAL SPONDYLOARTHRITIS

João Madruga Dias


MAY-JUNE16


OP0086

Thursday

09.06.2016

10:40

SpA and PsA

clinical

Capital Suite

11

Baraliakos X.

(Germany)

WHICH CELLS CORRESPOND TO THE

TYPICAL SIGNALS FOR FATTY AND

INFLAMMATORY LESIONS SEEN IN

MAGNETIC RESONSNCE IMAGING IN

ANKYLOSING SPONDYLITIS? A

PROSPECTIVE STUDY USING BIOPSY

MATERIAL OBTAINED DURING SPINAL

SURGERY.

OP0080

Thursday

09.06.2016

11:00

SpA and PsA basic

and translational

research

Capital Suite

11Poddubnyy D.

(Germany)

HIGH SERUM LEVEL OF LEPTIN MIGHT

BE RESPONSIBLE FOR LESS

STRUCTURAL DAMAGE IN THE SPINE IN

FEMALE PATIENTS WITH ANKYLOSING

SPONDYLITIS.

OP0082

Thursday

09.06.2016

11:20

SpA and PsA basic

and translational

research

Capital Suite

11

Lindström U.

(Sweden)

INFECTIONS OF THE GUT, UROGENITAL

AND RESPIRATORY TRACT AND

APPENDICITIS DURING CHILDHOOD,

AND THE RISK OF DEVELOPING

ANKYLOSING SPONDYLITIS.

OP0231

Friday

10.06.2016

10:20

Emerging concepts

in genomics &

genetics

Capital Suite

06

Roberts AR.

(United Kingdom)

DIFFERENTIAL TRANSCRIPTION

FACTOR BINDING COULD EXPLAIN THE

GENETIC ASSOCIATION OF

ANKYLOSING SPONDYLITIS WITH

POLYMORPHISMS IN THE IL-23R-

IL12RB2 INTERGENIC REGION.

OP0112

Friday

10.06.2016

11:00

Expanding

therapeutic options

in spondyloarthritis

Hall BSepriano A.

(Portugal)

EFFECT OF COMEDICATION WITH

CONVENTIONAL SYNTHETIC DMARDS

ON TNF INHIBITORS RETENTION IN

PATIENTS WITH SPONDYLOARTHRITIS:

A PROSPECTIVE COHORT.

POSTER

FRI0396

Friday

10.06.2016

11:50

Poster Tour: SPA-

clinical

Poster

Area

Baraliakos X.

(Germany)

WHICH IS THE MOST RELIABLE

IMAGING METHOD FOR DETECTION OF

STRUCTURAL CHANGES IN THE

SACROILIAC JOINTS OF PATIENTS WITH

ANKYLOSING SPONDYLITIS? A CROSS-

SECTIONAL STUDY COMPATING MRI,

CT AND CONVENTIONAL

RADIOGRAPHS.

POSTER

SAT0372

Saturday

11.06.2016

10:20

Poster Tour:

Optimising

treatment of axial

SpA

Poster

Area

Park JW.

(Korea)

IMPACT OF DOSE TAPERING OF

TUMOUR NECROSIS FACTOR-

BLOCKERS ON RADIOGRAPHIC

PROGRESSION IN THE ANKYLOSING

SPONDYLITIS-A 4 YEAR PROSPECTIVE

FOLLOW-UP FROM SINGLE CENTRE

COHORT.




Start

PAGE 10

Jan Leipe, MD has completed specialist training in rheumatology and general internal medicine and is currently an attending

physician at University of Munich, Germany. His major research interests include early RA and the role of T cells in the

pathogenesis of autoimmune arthritis.

SLE & APS

Jan Leipe


MAY-JUNE16


OP0042

Thursday

09.06.2016

10:50

Advances in SLE

TherapeuticsHall D

Md Yusof Md Y.

(United Kingdom)

HUMANISED ANTI-CD20 ANTIBODIES

IMPROVE DEPLETION AND

RESPONSE IN SLE PATIENTS WITH

RESISTANCE TO RITUXIMAB:

RESULTS FROM THE FIRST 100

PATIENTS AT A SINGLE CENTRE.

POSTER

THU0250

Thursday

09.06.2016

11:45

Poster Tour: Walk

through new

pathways,

biomarkers and

potential

treatments in SLE

and Sjögren’s

Poster

Area

Chiche L.

(France)

DYSREGULATION OF AUTOPHAGY IN

SYSTEMIC LUPUS ERYTHEMATOSUS

IS CORRELATED TO

TRANSCRIPTIONAL INTERFERON

SIGNATURES AND PROVIDES

CANDIDATE BIOMARKERS.

POSTER

FRI0309

Friday

10.06.2016

10:15

Poster Tour: SLE

and APS-Clinical

aspects

Poster

Area

Mohamed A.

(United Kingdom)

TYPE I INTERFERON ACTIVITY IS

ASSOCIATED WITH

MUCOCUTANEOUS BUT NOT

MUSCULOSKELETAL DISEASE

ACTIVITY IN SYSTEMIC LUPUS

ERYTHEMATOSUS.

POSTER

FRI0313

Friday

10.06.2016

10:15

Poster Tour: SLE

and APS-Clinical

aspects

Poster

Area

Riancho-Zarrabeitia L.

(Spain)

EVALUATION OF THROMBOTIC RISK

IN PATIENTS WITH POSITIVE

ANTIPHOSPHOLIPID ANTIBODIES

WITHOUT CLINICAL CRITERIA OF THE

DISEASE.

OP0183

Friday

10.06.2016

10:30

SLE, Sjögren's

and APS: clinical

aspects

Hall ADurcan L.

(United States)

HYPOCOMPLEMENTEMIA

ASSOCIATES WITH THROMBOSIS IN

SLE PATIENTS WITH

ANTIPHOSPHOLIPID ANTIBODIES.

POSTER

FRI0314

Friday

10.06.2016

11:45

Poster Tour: SLE

and APS-Clinical

aspects

Poster

Area

Zuily S.

(France)

ANTIPHOSPHOLIPID SYNDROME

ALLIANCE FOR CLINICAL TRIALS AND

INTERNATIONAL NETWORKING (APS

ACTION) CLINICAL DATABASE AND

REPOSITORY ANALYSIS: THE IMPACT

OF SYSTEMIC LUPUS

ERYTHEMATOSUS ON THE CLINICAL

PHENOTYPE OF ANTIPHOSPHOLIPID

ANTIBODY-POSITIVE PATIENTS.

OP0291

Saturday

11.06.2016

09:47

Session: SLE:

What will it be

and how will it be

treated 5 years

from now

Hall DFurie R.

(United States)

ANIFROLUMAB, AN ANTI-

INTERFERON-ALPHA RECEPTOR

MONOCLONAL ANTIBODY, IN

MODERATE TO SEVERE SYSTEMIC

LUPUS ERYTHEMATOSUS (SLE).

POSTER

SAT0285

Saturday

11.06.2016

All day

Poster Tour: SLE

and Sjögren’s-

Clinical aspects

Poster

Area

Chehab G.

(Germany)

VACCINATIONS IN SLE: COVERAGE

AND REASONS FOR NON-

VACCINATION - RESULTS FROM THE

LULA-STUDY.




Start

PAGE 11

OTHER CONNECTIVE TISSUE DISEASES

Including systemic sclerosis, myositis, vasculitis

Barbara Ruaro


MAY-JUNE16


OP0053

Thursday

09.06.2016

10:20

Vasculitis Hall AYates M.

(United Kingdom)

EULAR/ERA-EDTA

RECOMMENDATIONS FOR THE

MANAGEMENT OF ANCA-

ASSOCIATED VASCULITIS.

OP0038

Thursday

09.06.2016

11:40

Diagnosis and

management of

SSc

Hall CLi L.

(Canada)

IMPROVED SURVIVAL IN

DERMATOMYOSITIS AND

POLYMYOSITIS: A GENERAL

POPULATION-BASE STUDY.

OP0045

Friday

10.06.2016

10:20

Scleroderma,

myositis and

related

conditions

Capital Suite

01

Schniering J.

(Switzerland)

EARLY DETECTION OF LUNG

INVOLVEMENT IN SYSTEMIC

SCLEROSIS USING MOLECULAR

TARGETED IMAGING.

POSTER

FRI0252

Friday

10.06.2016

11:45

Poster Tour:

Scleroderma,

myositis and

related

syndromes I

Poster

Area

Khanna D.

(United States)

EFFICACY OF MYCOPHENOLATE

MOFETIL (MMF) VERSUS ORAL

CYCLOPHOSPHAMIDE (CYC) ON SKIN

THICKNESS IN THE SCLERODERMA

LUNG STUDY II.

POSTER

FRI0238

Friday

10.06.2016

11:45

Poster Tour:

From research

to biomarkers

and targeting

SSc

Poster

Area

Bosello S.

(Italy)

INCREASED SERUM FREE LIGHT

CHAINS OF IMMUNOGLOBULINS IN

SYSTEMIC SCLEROSIS PATIENTS:

CORRELATION WITH LUNG

INVOLVEMENT AND INFLAMMATORY

MILIEU.

POSTER

FRI0239

Friday

10.06.2016

11:45

Poster Tour:

From research

to biomarkers

and targeting

SSc

Poster

Area

Abignano G.

(United Kingdom)

COMPLEMENTARY VALUE OF ELF

TEST AND NT-PROBNP IN

REFLECTING FIBROSIS AND

VASCULOPATHY IN SYSTEMIC

SCLEROSIS.

OP0289

Friday

10.06.2016

16:35

Potential targets

in inflammatory

fibrotic

conditions in

SSc

Capital Suite

14

Rudnik M.

(Switzerland)

MICRORNAS AS POTENTIAL

REGULATORS OF MONOCYTE

DIFFERENTIATION AND FUNCTION IN

HEART FIBROSIS IN SYSTEMIC

SCLEROSIS.

POSTER

SAT0195

Saturday

11.06.2016

10:15

Poster Tour:

Scleroderma,

myositis and

related

syndromes II

Poster

Area

Felis-Giemza A.

(Poland)

EARLY NAILFOLD CAPILLAROSCOPIC

PATTERN PREDOMINATES IN

PATIENTS WITH MIXED CONNECTIVE

TISSUE DISEASE.

Barbara Ruaro, MD currently works in the Research Laboratory and Academic Division of Clinical Rheumatology,

Department of Internal Medicine, University of Genova, Italy. Her interests are connective tissue diseases, spondyloarthritis

and ultrasonography in rheumatology.




Start

PAGE 12

Christian Dejaco, MD PhD MBA is a consultant and associate professor at the Medical University Graz. His main research

interests are the value of ultrasound in psoriatic arthritis and vasculitis, clinical research on polymyalgia rheumatica and

translational research on T lymphocyte senescence in rheumatology. He is the country liaison for EMEUNET in Austria.

IMAGING

Christian Dejaco


MAY-JUNE16


OP0177

Thursday

09.06.2016

10:40

Prognosis and

outcome in RAHall B

Haavardsholm EA.

(Norway)

ULTRASOUND IN THE MANAGEMENT OF

RHEUMATOID ARTHRITIS: RESULTS

FROM THE RANDOMIZED CONTROLLED

ARCTIC TRIAL.

OP0124

Thursday

09.06.2016

11:20

New insights

into imagingS20

Glimm AM.

(Germany)

IMAGING REMISSION BY

MUSCULOSKELETAL ULTRASOUND

LEADS TO A BETTER FUNCTIONAL

OUTCOME – RESULTS OF THE US

IMPERA STUDY - US 7-SCORE

IMPLEMENTATION STUDY IN EARLY


POSTER

FRI0514

Friday

10.06.2016

11:45

Poster Tour:

Imaging in

RMD-Adding

value

Poster

Area

Ez-Zaitouni Z.

(Netherlands)

ADDING MRI OF THE SPINE TO THE

ASAS CLASSIFICATION CRITERIA FOR

AXIAL SPONDYLOARTHRITIS,

REDUNDANT OR BENEFICIAL? DATA

FROM THE SPONDYLOARTHRITIS

CAUGHT EARLY (SPACE)-COHORT.

OP0266

Friday

10.06.2016

14:45

The role of

nuclear

medicine in

rheumatology

Hall CBruijnen S.

(Netherlands)

BASELINE 89ZR-RITUXIMAB PET MAY

PREDICT THERAPEUTIC RESPONSE 24

WEEKS AFTER INITIATION OF

RITUXIMAB TREATMENT IN

RHEUMATOID ARTHRITIS PATIENTS.

POSTER

FRI0546

Friday

10.06.2016

All day

Poster Session:

Diagnostic and

imaging

procedures

Poster

Area

Husic R.

(Austria)

THE POWER DOPPLER RESULT IN

RHEUMATOID ARTHRITIS DEPENDS ON

THE POSITION OF HANDS DURING

ULTRASOUND EXAMINATION.

OP0292

Saturday

11.06.2016

09.35

Clinical

outcomes for

PMR / GCA

Hall AKume K.

(Japan)

INTERSPINOUS BURSITIS EVALUATION

BY ULTRASOUND IS VERY USEFUL FOR

DIAGNOSIS OF POLYMYALGIA

RHEUMATICA.

POSTER

SAT0216

Saturday

11.06.2016

All day

Poster session:

Scleroderma,

myositis and

related

syndromes

Poster

Area

Rotondo C.

(Italy)

CHEST ULTRASOUND SIGNS OF

INTERSTITIAL LUNG DISEASE IN

SYSTEMIC SCLEROSIS PATIENTS: A

COMPARISON BETWEEN HIGH

RESOLUTION CHEST COMPUTED

TOMOGRAPHY FINDINGS.

POSTER

SAT0541

Saturday

11.06.2016

All day

Poster Session:

Diagnostic and

imaging

procedures

Poster

Area

Latourte A.

(France)

MORE THAN HALF OF DIFFUSE

IDIOPATHIC SKELETAL HYPEROSTOSIS

PATIENTS MAY FULFILL THE ASAS

DEFINITION OF A POSITIVE MRI OF THE

SPINE: A RETROSPECTIVE ANALYSIS

OF 53 CASES.




Start

PAGE 13

Marie Kostine, MD is a clinical fellow in Rheumatology at Bordeaux Hospital, France. She is currently working as a PhD

candidate at the Leiden University Medical Center, Netherlands, on immune infiltrate in bone and soft-tissue tumours.

OSTEOARTHRITIS & OSTEOPOROSIS

Marie Kostine


MAY-JUNE16


OP0069

Thursday

09.06.2016

10:30

Cartilage, bone,

synovium

Capital Suite

06

Hood J.

(USA)

DISCOVERY OF A SMALL

MOLECULE INHIBITOR OF THE

WNT PATHWAY (SM04690) AS A

POTENTIAL DISEASE MODIFYING

TREATMENT FOR KNEE

OSTEOARTHRITIS.

OP0101

Thursday

09.06.2016

10:30

Clinical

osteoporosis:

new insights

Capital Suite

02

Sokal A.

(France)

BISPHOSPHONATES DURING

PREGNANCY: A PROSPECTIVE

STUDY.

OP0098

Thursday

09.06.2016

11:20

New horizons in

osteoarthritis

Capital Suite

14

Kroon F.

(Netherlands)

EFFECT OF ETANERCEPT ON

SYNOVITIS AND BONE MARROW

LESIONS IN EROSIVE HAND

OSTEOARTHRITIS.

OP0135

Thursday

09.06.2016

14:45

Lubricants:

potential as

osteoarthritis

treatment?

Capital Suite

14

Eymard F.

(France)

PREDICTIVE FACTORS OF

FAILURE OF

VISCOSUPPLEMENTATION IN

PATIENTS WITH KNEE

OSTEOARTHRITIS. RESULTS OF

A POST-HOC ANALYSIS OF A

DOUBLE BLIND, CONTROLLED

NON INFERIORITY TRIAL.

OP0143

Thursday

09.06.2016

16:35

Joint

replacement in

OA: Friend or

Foe?

Hall CAitken D.

(Australia)

THE EFFECT OF PHYSICAL

ACTIVITY ON THE RISK OF TOTAL

JOINT REPLACEMENT FOR

SEVERE KNEE OR HIP

OSTEOARTHRITIS: A

POPULATION-BASED

PROSPECTIVE COHORT STUDY.

POSTER

SAT0430

Saturday

11.06.2016

10:15

Poster Tour:

New insights in

osteoarthritis

Poster

Area

Magnusson K.

(Norway)

NEITHER OBESITY, SMOKING

AND ALCOHOL ARE ASSOCIATED

WITH HAND OSTEOARTHRITIS-

LONGITUDINAL DATA FROM

OSTEOARTHRITIS INITIATIVE

(OAI).

OP0306

Saturday

11.06.2016

13:20

Paget’s and

other rare bone

diseases

Hall CPapapoulos S.

(Netherlands)

TEN YEARS OF DENOSUMAB

TREATMENT IN

POSTMENOPAUSAL WOMEN

WITH OSTEOPOROSIS: RESULTS

FROM THE FREEDOM

EXTENSION TRIAL.




Start

PAGE 14

Mike Becker, MD is a board certified rheumatologist and has been a clinical and research fellow in the Department of

Rheumatology and Clinical Immunology at the Charité Medical Faculty in Berlin, Germany, until 2016 and recently joined the

Department of Rheumatology at the University Hospital Zürich, Switzerland. interests are connective tissue diseases,

especially systemic sclerosis.

METABOLIC & CRYSTAL ARTHROPATHIES

Mike Becker


MAY-JUNE16


OP0017

Wednesday

08.06.2016

18:05

Outcome measures

in clinical practice in

gout and CPPD. The

use of the new

EULAR guidelines

Hall A Scheepers LE.

(Netherlands)

MEDICATION TAKING

BEHAVIOUR OF ALLOPURINOL

TREATMENT AMONG PATIENTS

WITH GOUT: A RETROSPECTIVE

COHORT STUDY IN THE

CLINICAL PRACTICE RESEARCH

DATALINK (CPRD).

OP0018

Wednesday

08.06.2016

18:05

Outcome measures

in clinical practice in

gout and CPPD. The

use of the new

EULAR guidelines

Hall A Nossent J.

(Australia)

HYPERURICEMIA INCREASES

MORTALITY ONLY IN PATIENTS

WITH GOUT AND EXISTING

CARDIOVASCULAR DISEASE. A

PROSPECTIVE ANALYSIS FROM

THE BUSSELTON HEALTH

STUDY.

POSTER

THU0498

Thursday

09.06.2016

11:45

Poster Tour: Crystal

and metabolic bone

diseases; bone

diseases other than

osteoporosis

Poster

Area

Fransen J.

(Netherlands)

GENDER DIFFERENCES IN THE

PHENOTYPE OF GOUT AND ITS

EFFECT ON CLASSIFICATION

USING THE ACR-EULAR

CRITERIA.

POSTER

THU0524

Thursday

09.06.2016

All day

Poster session:

Crystal disease,

metabolic bone

diseases and bone

diseases other than

osteoporosis

Poster

Area

Frallonardo P.

(Italy)

THE EFFECTIVENESS OF

METHOTREXATE IN PATIENTS

WITH RESISTANT CHRONIC

CALCIUM PYROPHOSPHATE

CRYSTAL ARTHRITIS.

POSTER

THU0527

Thursday

09.06.2016

All day

Poster session:

Crystal disease,

metabolic bone

diseases and bone

diseases other than

osteoporosis

Poster

Area

Khanna PP.

(USA)

LESINURAD, A SELECTIVE URIC

ACID REABSORPTION

INHIBITOR, IN COMBINATION

WITH XANTHANE OXIDASE

INHIBITORS: SUA AND FLARES

COMPOSITE ENDPOINT FROM

PHASE III STUDIES IN GOUT

PATIENTS (CLEAR 1, CLEAR 2

AND CRYSTAL).

OP0287

Friday

10.06.2016

16:35

Inflammasome as

therapeutic target in

inflammatory

diseases-

Capital Suite

11

Campillo-Gimenez L.

(France)

CALCIUM PYROPHOSPHATE

DIHYDRATE CRYSTALS INDUCE

IL-1Β PRODUCTION BY

MONOCYTES THROUGH A

POTASSIUM EFFLUX-

DEPENDENT PATHWAY.

POSTER

SAT0542

Saturday

11.06.2016

All day

Poster session:

Diagnostic and

imaging procedures

Poster

Area

Toscano C.

(Italy)

THE PREVALENCE OF CALCIUM

PYROPHOSPHATE DEPOSITS AT

ULTRASOUND EXAMINATION:

RETROSPECTIVE ANALYSIS IN A

COHORT OF PATIENTS.




Start

PAGE 15

PEDIATRIC RHEUMATOLOGY

W. Alberto Sifuentes Giraldo


MAY-JUNE16


OP0012

Wednesday

08.06.2016

16:15

Lessons from

the children

(monogenic

causes of

autoimmunity)

Capital Suite

02

Thornton S.

(United States)

MICRORNA ASSOCIATED WITH

ACTIVE SYSTEMIC JUVENILE

IDIOPATHIC ARTHRITIS

REGULATE CD163

EXPRESSION IN POLARIZED

MACROPHAGES THROUGH

TWO DISTINCT MECHANISMS.

POSTER

THU0221

Thursday

09.06.2015

11:45

Poster Tour:

Arthritis in

childhood

Poster

Area

Aktay Ayaz N.

(Turkey)

EFFICACY OF BIOLOGICAL

AGENTS IN COLCHICINE

RESISTANT CHILDREN WITH

FMF.

OP0215

Friday

10.06.2016

10:20

Advances in

pediatric

rheumatology

Capital Suite

02

Ruperto N.

(Italy)

SUBCUTANEOUS ABATACEPT

IN PATIENTS WITH

POLYARTICULAR JUVENILE

IDIOPATHIC ARTHRITIS AND

INADEQUATE RESPONSE TO

BIOLOGIC OR NON-BIOLOGIC

DISEASE-MODIFYING

ANTIRHEUMATIC DRUGS:

PHARMACOKINETICS,

EFFICACY AND SAFETY.

OP0221

Friday

10.06.2016

11:20

Prognosis and

outcome in RA

Capital Suite

02

Campanilho-Marques R.

(United Kingdom)

EFFICACY AND SAFETY OF

TUMOUR NECROSIS FACTOR-Α

ANTAGONISTS IN A LARGE

COHORT OF JUVENILE

DERMATOMYOSITIS PATIENTS.

OP0275

Friday

10.06.2016

14:45

Role of imaging

in childhood-

onset rheumatic

diseases

Capital Suite

02

Collado P.

(Spain)

PREVALENCE OF

ULTRASOUND-DETECTED

FINDINGS IN FOOT IN

JUVENILE IDIOPATHIC

ARTHRITIS VERSUS HEALTHY

CHILDREN: ASSOCIATION TO

PAEDIATRIC FOOT POSTURE.

POSTER

SAT0254

Saturday

11.06.2015

10:15

Poster Tour:

Juvenile-onset

connective

tissue diseases

Poster

Area

Sezgin S.

(Turkey)

THE ICEBERG IN JUVENILE

ONSET SYSTEMIC LUPUS

ERYTHEMATOSUS:

SUBCLINICAL DETERIORATION

OF CARDIAC FUNCTIONS

ASSESSED WITH TWO-

DIMENSIONAL SPECKLE

TRACKING

ECHOCARDIOGRAPHY AND

CONTRIBUTING FACTORS OF

SYSTOLIC DYSFUNCTION.

W. Alberto Sifuentes Giraldo, MD is a research associate at the Department of Rheumatology of the University Hospital

Ramon y Cajal, Madrid, Spain. His main research interest focuses on pediatric rheumatology, spondyloarthritis and biological

therapies.


Ursprungsform

im Menü über:


THE YOUNG RHEUMATOLOGIST SESSIONS

PAGE 16

Wednesday 08.06.2016

15:00 - 16:30

Wednesday 08.06.2016

17:00 - 18:30

THE YOUNG RHEUMATOLOGIST

SESSIONS (1)

ABC of statistics

Chair: Aletaha Daniel (Austria)

Chair: Ramiro Sofia (Netherlands)

Speaker: Michaud Kaleb (United States) STATISTICS IN RESEARCH IN

RHEUMATOLOGY - HOW TO MAKE THE BEST USE OF IT?

Speaker: Norton Sam (United Kingdom) SP0026 THE BASICS OF A

REGRESSION ANALYSIS

Speaker: Carmona Loreto (Spain) SP0027 CONFOUNDING - FRIEND OR

FOE? HOW TO HANDLE?

Abstract: Sergeant Jamie (United Kingdom) OP0013 PREDICTION OF NON-

RESPONSE TO METHOTREXATE THERAPY IN THE RHEUMATOID

ARTHRITIS MEDICATION STUDY (RAMS)

Beyond EMEUNET: development of a European-wide network of young

clinicians from different specialties focusing on inflammatory diseases

Chair: Gossec Laure (France)

Chair: Richez Christophe (France)

Speaker: Moltó Anna (France) SP0053 EXPERIENCES FROM YOUNG

RHEUMATOLOGISTS INTO EMEUNET

Speaker: Hindryckx Pieter (Canada) SP0054 EXPERIENCES FROM YOUNG

GASTROENTEROLOGISTS INTO Y-ECCO

Speaker: Smith Eve (United Kingdom) SP0055 EXPERIENCES FROM

YOUNG REPRESENTATIVE OF PAEDIATRIC RHEUMATOLOGY

EUROPEAN SOCIETY

Speaker: da Costa Ferreira Ana Carina (Portugal) SP0056 EXPERIENCES

FROM THE YOUNG NEPHROLOGISTS’ PLATFORM

MAY-JUNE16

All sessions will be held in Capital Suite 01


Ursprungsform

im Menü über:



PAGE 17

Thursday 09.06.2016

13:30-15:00

Thursday 09.06.2016

15:30-17:00


SESSIONS (2)

The elephant in the room: how to avoid biases in research?

Chair: Boers Maarten (Netherlands)

Chair: Aydin Sibel Zehra (Turkey)

Speaker: Aletaha Daniel (Austria) RISK OF BIAS WHEN DESIGNING A TRIAL

Speaker: Landewé Robert B.M. (Netherlands) RISK OF BIAS WHEN CONDUCTING A

TRIAL

Speaker: Yazici Hasan (Turkey) SP0090 RISK OF BIAS WHEN REPORTING A TRIAL

Presenter: Sepriano Alexandre (Portugal) EFFECT OF COMEDICATION WITH

CONVENTIONAL SYNTHETIC DMARDS ON TNF INHIBITORS-RETENTION IN

PATIENTS WITH SPONDYLOARTHRITIS: A PROSPECTIVE COHORT

Abstract: Richter Adrian (Germany) OP0138 SIMPLE POOLING OF DATA FROM

DIFFERENT STUDIES IS INCREASINGLY USED BUT NOT IN LINE WITH

METHODOLOGICAL RECOMMENDATIONS: A SYSTEMATIC REVIEW

OF METHODS APPLIED IN THE FIELD OF RHEUMATOID ARTHRITIS

MAY-JUNE16

Teaching clinical skills

Chair: Doherty Michael (United Kingdom)

Chair: Romao Vasco C (Portugal)

Speaker: Doherty Michael (United Kingdom) SP0109 HOW TO PERFORM CLINICAL

HISTORY AND PHYSICAL EXAMINATION?

Speaker: Caporali Roberto (Italy) HOW TO READ A PLAIN JOINT X-RAY?

Speaker: Hafler Janet (United States) SP0110 THE ART OF TEACHING

RHEUMATOLOGY: TIPS AND TRICKS

Presenter: Kosevoi Alexandra (Romania) RELATIONSHIP BETWEEN ULTRASOUND-

DETECTED SYNOVITIS, QUALITY OF LIFE AND WORK PRODUCTIVITY IN

PATIENTS WITH RHEUMATOID ARTHRITIS OF WORKING AGE

Abstract: Sukhdeo Aishwarya (Australia) OP0151 A STUDY ON MEDICAL STUDENTS

LEARNING ULTRASOUND IN RHEUMATOID ARTHRITIS (ASMSLURA)


Ursprungsform

im Menü über:



PAGE 18

Friday 10.06.2015

13:30-15:00

Friday 10.06.2015

15:30-17:00


SESSIONS (3)

Chair: Skingle Diana (United Kingdom)

Chair: Alunno Alessia (Italy)

Speaker: Nikiphorou Elena (United Kingdom) SP0141 THE POINT OF VIEW OF

PHYSICIAN. SOCIAL MEDIA: PROS AND CONS OF SHARING PATIENT AND

PHYSICIAN PERSONAL EXPERIENCE

Speaker: van Nieuwkoop Linda (Netherlands) THE POINT OF VIEW OF PATIENTS.

ROLE OF INTERACTIVE MEDIA IN ACCESSING MEDICAL INFORMATION AND IN

BUILDING PATIENT-PHYSICIAN RELATIONSHIP

Faculty: INTERACTIVE OPEN DISCUSSION

Abstract: Vliet Vlieland Theodora (Netherlands) OP0276 POSTGRADUATE

RHEUMATOLOGY EDUCATION FOR HEALTH PROFESSIONALS IN

RHEUMATOLOGY: AVAILABILITY, NEEDS AND BARRIERS

Abstract: Clausen Jürgen (Germany) OP0277-PARE PATIENT RESEARCH

PARTNERS INVOLVED IN A PROJECT TO ENHANCE DISEASEASSOCIATED

COMMUNICATIONS SKILLS OF RHEUMATOID PATIENTS.

Physician-patient relationship in the era of interactive media

How to get into the international world of rheumatology

Chair: Sivera Francisca (Spain)


Speaker: Moltó Anna (France) THE ROLE OF EMEUNET

Speaker: Machado Pedro (Portugal) OPPORTUNITIES ABROAD

Speaker: Dougados Maxime (France) COLLABORATIVE EU PROJECTS – HOW TO

GET INVOLVED?

Presenter: Fragoulis George E. (Greece) SICCA SYMPTOMS IN RHEUMATOID

ARTHRITIS: REAL SJOGREN'S OR NOT?

Presenter: Selickaja Sandra (Lithuania) ANTI-TIF1-GAMMA ANTIBODIES – MARKERS

OF PARANEOPLASTIC MYOSITIS BUT NOT OF PARANEOPLASTIC RHEUMATIC

SYNDROMES OR SOLID TUMORS

MAY-JUNE16


Ursprungsform

im Menü über:



PAGE 19

Saturday 11.06.2015

08:30-10:00

Saturday 11.06.2015

12:00-13:30


SESSIONS (4)

Career paths in research - how to start and where to go?

Chair: Buch Maya (United Kingdom)


Speaker: Askling Johan (Sweden) TESTIMONIES OF CLINICAL RESEARCH

Speaker: Schett Georg (Germany) TESTIMONIES OF BASIC/TRANSLATIONAL

RESEARCH

Speaker: van der Heijde Désirée (Netherlands) THE VIEW AND ADVICE OF AN

EXPERT

Presenter: Fernandes Silvia (Portugal) VITAMIN DEFICIENCY AND DISEASE

ACTIVITY/SEVERITY IN SPONDYLOARTHRITIS: RESULTS OF THE ASAS-

COMOSPA INTERN. STUDY

Presenter: Tombetti Enrico (Italy) TAKAYASU ARTERITIS: CLINIMETRY,

PROGRESSION AND CORONARY INVOLVEMENT

Presenter: Soare Alina (Romania) NEW FIBROSIS MECHANISM IN SYSTEMIC

SCLEROSIS AND POTENTIAL TREATMENT TARGETS

Presenter: Perniola Simone (Italy) SPECIALIZED PRO-RESOLVING MEDIATOR

RECEPTORS IN OSTEOARTHRITIC SYNOVIUM AND CARTILAGE

EULAR educational offer

Chair: Mandl Peter (Austria)

Chair: Sepriano Alexandre (Portugal)

Speaker: Hachulla Eric (France) SP0197 EULAR EDUCATIONAL OFFER: WHERE

ARE WE NOW?

Speaker: Haines Catherine (United Kingdom) SP0198 A MASTERCLASS ON

ASSESSMENT QUESTIONS IN ONLINE COURSES

Speaker: Naredo Esperanza (Spain) SP0199 DEVELOPMENTS IN EULAR

EDUCATIONAL PROJECTS IN ULTRASOUND

Speaker: Iagnocco Annamaria (Italy) SP0200 COMPETENCY ASSESSMENT IN US:

AN EXAMPLE OF QUALIFICATION OFFERED BY EULAR

Faculty: Q&A AND ACTIVE DISCUSSION

MAY-JUNE16


Ursprungsform

im Menü über:


EMEUNET SOCIAL EVENTS AT EULAR 2016

PAGE 20

EMEUNET Sightseeing tour of London by

cable car and boat

Thursday 9 June, 5:30 pm

EMEUNET has organized a ride with

breathtaking views of London on the Emirates

cable car, flying from the Royal Docks to North

Greenwich, followed by a boat trip from North

Greenwich to the London Eye. If you missed

the registration meet us later (see below).

Get together at Doggett's coat and badge pub

Thursday 09 June, after the cable car/boat tour

around 8:30 pm

EMEUNET evening is an excellent opportunity

to meet other EMEUNET members and to make

new contacts and friends around the world. Join

us at the Doggett's coat and badge pub, 1

Blackfriars Bridge,London SE1 9UD, London.

The traditional EMEUNET Booth will this

year be located at V31 in the EULAR

Village. As previous years, this will be a key

meeting point for young rheumatologists,

where they can receive information on the

great work of EMEUNET and can be

actively encouraged to sign up. Additionally,

it will also serve as a point of contact for

existing members to come say hello and

meet their fellow members.

EMEUNET BOOTH

MAY-JUNE16

EMEUNET EVENTS AT EULAR 2016


Ursprungsform

im Menü über:


YOUR OPINION IS IMPORTANT!

If you are one of the mentees that will participate to the meetings give us your feedback after the

event and it will be included in next Newsletter issue!

EDUCATIONAL ACTIVITIES

PAGE 21

THE MENTOR MENTEE MEETINGS AT EULAR 2016

EMEUNET offers you an unique opportunity to discuss about possible career options, your

research and your involvement in EULAR with leaders in the field in an informal way. Sign up

for the mentor-mentee meetings at EULAR 2016, London. As you all know, one of the missions

of EMEUNET is increasing the mentor-mentee interaction. Previous mentor-mentees meetings

at EULAR and ACR have been very interactive and were scored very satisfactory by mentees.

The next mentor-mentee will take place on Thursday 9th of June at 6 PM in Room S14 and will

last approximately 1 hour. The number of mentees will be limited to 4-6 for each group to enhance

interaction. Here are the 3 professors that will guide as mentors:

PROFESSOR: Alfred Mahr (Hopital Saint-Louis, Paris/France)

AREA: Epidemiology of vasculitis, in particular Churg-Strauss Syndrome

PROFESSOR: . Deborah Symmons (University of Manchester/UK):

AREA: Epidemiology of inflammatory musculoskeletal conditions with emphasis on development

and outcome of rheumatoid arthritis. Clinical trials and drug safety.

PROFESSOR: Philip Conaghan (University of Leeds/UK):

AREA: Translational studies and clinical trials in understanding and treatment of rheumatoid

arthritis, psoriatic arthritis and osteoarthritis

MAY-JUNE16


Ursprungsform

im Menü über:



PAGE 22

THE EULAR-EMEUNET AMBASSADOR PROGRAMME

FOR FIRST TIME ATTENDEES

Attending the largest European Rheumatology congress for the first time can be a daunting

experience. The annual EULAR meeting welcomes around 14,000 clinicians and scientists,

discussing clinical management and new scientific findings in an overwhelming number of sessions

which run in parallel, starting early in the morning and ending late at night. There has been a long

tradition that senior attendees share the skills on how to survive the annual EULAR meeting, on

how to get a taste of everything and not miss the important facts, and have a great time. But how

can you find your way through countless opportunities within four days?

We invite 30 fellows who are first or second-time attendees to the conference to be part of our

EULAR/EMEUNET ambassador programme and receive congress mentorship from EULAR

veterans on how to make the most of your time. The details are as follows:

The EMEUNET Ambassator meeting will take place on June 8th at 12:00 pm in Room S11

o Applicants will be selected on a first-come, first-served basis

o Participants will be allocated to small groups, each with a EULAR ambassador from EMEUNET.

Your ambassador will get in contact with you prior to the meeting

o You will be invited to the welcome meeting on the first day of the congress, so that you can meet

other fellow first time attendees and your ambassadors too in an informal setting

o Participants will learn how to master the clinical and scientific EULAR programme

o Participants will be offered the chance to participate in the EMEUNET social activities

o The mentoring process will be very informal

o The programme is for free for EMEUNET members and non-members

YOUR OPINION IS

IMPORTANT!

If you are one of the participants

to the programme give us your

feedback after the event and it

will be included in next

Newsletter issue!

MAY-JUNE16


Ursprungsform

im Menü über:



PAGE 23

THE 3RD COUNTRY LIAISONS MEETING AT EULAR 2016

The Country Liaisons are the ambassadors of EMEUNET in the EULAR countries. They are the

ones in charge of advertising and expanding the EMEUNET Network at a national level. Through

them, the educational and career development opportunities offered by EMEUNET/EULAR find

their way to the young Rheumatology fellows/researchers, both members and non- members of

EMEUNET alike.

In the Country Liaison Subgroup, division of the EMEUNET Working Group, we work together with

the 45 current EMEUNET Country Liaisons. Last year, we organized the first Country Liaison

Meeting during the EULAR Congress in Paris. This was a first opportunity to meet in person many

of the Country Liaisons and to discuss about their experiences in promoting EMEUNET. It was a

lively and productive talk, during which various points were raised and exciting ideas were shared,

which we did our best to develop during the past year.

After the success of the first meeting, the second Country Liaison Meeting is going to take place

during the upcoming EULAR Congress in Rome. On Thursday, June 9th, from 5 to 6 PM, we

invite once again the EMEUNET Country Liaisons to group together! We will review the

highlights of the past year and invited Country Liaisons will share their experience in promoting

EMEUNET in their home countries. We count on your participation for an exciting discussion and

feedback!

EMEUNET Country Liaisons everywhere, book the date: Thursday, June 9th, from 5 to 6 PM,

Room S14, EULAR Congress Venue-Excel Exhibition Center, London

See you in London!

Your EMEUNET Country Liaison Subgroup

YOUR OPINION IS

IMPORTANT!

If you are one of the CLs that

will participate to the meeting

give us your feedback after

the event and it will be included

in next Newsletter issue!

MAY-JUNE16

2nd Country liaisons meeting

at EULAR 2015


Ursprungsform

im Menü über:


UPCOMING EDUCATIONAL EVENTS AT A GLANCE

PAGE 24

JUNE 2016

JULY 2016

EDUCATIONAL EVENTS

JUNE-JULY 2016

17° EFORT Annual Congress

o When and Where: 1-3 June, Geneva, Switzerland

o Website: https://www.efort.org/17th-efort-congress-2016-geneva-ch-1-3-june

23rd EULAR Ultrasound Course

o When and Where: 5-7 June, London, United Kingdom

o Website: http://www.eular.org/edu_course_ultrasound.cfm

5th EULAR Course for Ultrasound Trainers in Rheumatology


o Website: http://www.eular.org/edu_cours e_ultrasound.cfm

EULAR Congress


o Website: http://www.congress.eular.org/

ESSR 2016 Meeting

o When and Where: 9-11 June, Zürich, Switzerland

o Website: http://www.essr.org/cms/website.php?id=/en/index/congress_2016.htm

FOCIS 2016

o When and Where: 22-25 June, Boston, MA

o Website: http://www.focisnet.org/2013-03-07-14-01-50/2015-annual-meeting

13th International Conference on Innate Immunity

o When and Where: 23-28 June, Rhodes, Greece

o Website: http://www.aegeanconferences.org/src/App/conferences/view/104

Bone Research Society Annual Meeting 2016

o When and Where: 29 June-1 July , Liverpool, United Kingdom

o Website: http://boneresearchsociety.org/meetings/#7

Advanced Musculoskeletal Epidemiology Summer School

o When and Where: 4-8 July , Manchester, United Kingdom

o Website: http://tinyurl.com/ameSummerSchool

MAY-JUNE16

http://www.eular.org/edu_course_ultrasound.cfm

http://www.congress.eular.org/

http://www.essr.org/cms/website.php?id=/en/index/congress_2016.htm

http://www.aegeanconferences.org/src/App/conferences/view/104

http://tinyurl.com/ameSummerSchool


Ursprungsform

im Menü über:


MORE ON EDUCATION

PAGE 25

THE EULAR ON-LINE COURSES

All EULAR courses, as electronic ways of continuous medical education in rheumatology, are

managed by a scientific course committee responsible for the structure and content of the courses

and for ensuring regular quality control and advancement. Teams of expert authors are regularly

reviewing and updating the courses to keep up with the newest developments in the field.

REGISTRATION IS NOW OPEN

Course Duration Link to course content

11th EULAR On-line Course on

Rheumatic Diseases 2 years

http://www.eular.org/myUploadData/files/Online_full

_module_planner.pdf

8th EULAR On-line Course on

Connective Tissue Diseases (CTD) 9 months

http://www.eular.org/myUploadData/files/CTD%20w

eb%20overview%20modules_2012%20(2).pdf

6th EULAR On-line Course on Systemic

Sclerosis (SSc) 9 months

http://www.eular.org/myUploadData/files/SSc%20w

eb%20overview%20modules_2012.pdf

5th EULAR On-line Introductory

Ultrasound Course 7 months

http://www.eular.org/myUploadData/files/MSUS%2

0Module%20Planner.pdf

3rd EULAR / PReS On-line Course in

Paediatric Rheumatology9 months

http://www.eular.org/edu_online_course_paediatric.

cfm

2nd EULAR On-line Course for Health

Professionals 9 months

http://www.eular.org/myUploadData/files/HP%20we

b%20overview%20modules_2015.pdf

The EULAR On-line Courses on Rheumatic Diseases,

CTDs, SSc and US are also available as APP

THE OPINION OF TWO PARTICIPANTS:

“Ultrasonography is essential for the training of Rheumatologists and represents a key aspect of patient’s evaluation. The

EULAR On-line Introductory Ultrasound Course offers theoretical basic skills on musculoskeletal ultrasound in rheumatic

diseases as well as in healthy subjects. The high quality of contents as well as the experience of the Faculty are the two

main reasons to join this course. Moreover, the website is straightforward and very easy to use. Upon passing the final

examination, EULAR releases a certificate. This course is very useful for Rheumatologists who would like to acquire a

basic theoretical knowledge on musculoskeletal ultrasound.”

“I attended the EULAR On-line Introductory Ultrasound Course. It is a well structured basic course on ultrasonography that

is divided in different modules according to the different anatomical sites. Each module includes specific exercises and the

final test. I found this course very interesting and it provided me with a complete overview of ultrasonography in

rheumatology. I would recommend this course as to me it was overall more useful and formative compared to some

different on-site courses I previously attended.”

MAY-JUNE16


Ursprungsform

im Menü über:


MORE ON EDUCATION

PAGE 26

The aim of this intensive and interactive EULAR CAP course is to provide all participantswith an update on the power of the safe and non-invasive nailfoldvideocapillaroscopy (NVC) technique in the field of rheumatic diseases, in particularfor the early diagnosis of the scleroderma spectrum diseases, its predictability andprognostic value, as well as its role as a tool for the therapeutic follow up.

Participants will be fully involved in interactive theoretical and practical capillaroscopicsessions (Learning and Testing sessions) engaging a large number of rheumaticpatients. Updated clinical sessions concerning the diagnostic/prognostic value of NVC indiseases such as systemic sclerosis and the effects of targeted therapies onmicrocirculation and immune-inflammatory reaction will represent a stimulating gym basedon large clinical cases discussion. Links between the CAP patterns and biomarkers suchas autoantibodies will also be updated since evoluted.In particular, reading and scoring (manual and automated systems) of thevideocapillaroscopic images of living patients will be discussed and their predictive value toidentify possible clinical complications (i.e. digital ulcers in systemic sclerosis, lunginvolvement etc.) will be analyzed including in the pediatric population. Recent internationalstudies reported (CAP study) about new predictive models or index based oncapillaroscopic analysis. New sessions on practical evaluation of the peripheral bloodflow by laser doppler and LASCA imaging have been introduced. Lessons andpractical session on skin ultrasound (US) evaluation will be also available and will becombined with the severity of the videocapillaroscopic images (patterns) in living patients.Important links between CAP, laser blood flow analysis and clinical results of therapies, willbe presented and discussed for the follow up of patients.At the end of this top course that is supported by a tutorial team formed by some of thebest worlds experts on the matter, the participants will be able to use the capillaroscopy fortheir day-to-day staging and follow-up in particular of patients affected by sclerodermaspectrum diseases.

Next EULAR Course on Capillaroscopy will take place on 8-10 September 2016 in Genova, Italy

REGISTER NOW TO SAVE YOUR PLACE!TRAVEL BURSARIES ALSO AVAILABLE

For information and to register visit: http://www.eular.org/edu_course_capillaroscopy.cfm

THE EULAR COURSE ON CAPILLAROSCOPY

MAY-JUNE16

http://www.eular.org/edu_course_capillaroscopy.cfm


Ursprungsform

im Menü über:


MORE ON EDUCATION

PAGE 27

THE EULAR POSTGRADUATE COURSE

With its postgraduate course, EULAR seeks to update the professional knowledge of young

rheumatologists from around the world, whilst giving the participants the opportunity to meet and

exchange ideas and experiences. Target participants are fellows/residents in rheumatology,

clinician scientists in rheumatology, newly certified rheumatologists as well as more experienced

rheumatologists who need to remain up-to-date in rheumatology and immunology. A unique 3 day

refresher, "crash course", in clinical and experimental rheumatology taught by selected faculty of

European experts in a very interactive and cordial environment. Participants have the opportunity

to meet the experts in an informal setting and network with trainees and rheumatologists from all

over the world. The course includes interactive workshop sessions and participants choose which

to attend (How to design a clinical trial in rheumatic diseases, how to study adverse events of new

therapies, how to design a study to understand risk factors, how to design a study to define critical

molecular pathways in a rheumatic disease, how to review an abstract, how to write a paper).

Next EULAR Postgraduate Course will take place on23-26 october 2016 in Prague, Czech Republic

REGISTRATION OPENS IN MAY, TRAVEL BURSARIES ALSO AVAILABLE

For more information and to register: http://www.eular.org/edu_course_postgraduate.cfm

THE OPINION OF A PARTICIPANT:

Is it possible to learn the many facets of rheumatology within three days, discuss the arthritides, vasculitides and

connective tissue diseases, and make new friends from all over the world? No, of course, that’s not very realistic, but

the EULAR Postgraduate Course comes very close to fulfilling these challenges. The three day course is designated

to clinical residents and fellows who already have solid knowledge and basic skills in rheumatology. Based on that,

the participants acquire general scientific and in-depth clinical knowledge about the major rheumatic diseases. The

programme covers a great deal of what clinicians really need to know in their clinical routine, presented and

discussed by world-leading experts of the field of rheumatology. With participants from Europe, Africa, and the Near

East, the EULAR Postgraduate Course is international and exciting. It’s amazing to learn that the standard of care in

rheumatology is high worldwide, and fascinating to discover the subtle differences in how clinical practice looks like in

various countries. Despite a very dense and compacted schedule, the course offers enough leaves to exchange one’s

experiences with international fellow students from all over the world. One central element of the EULAR

Postgraduate Course is the vivid interaction between teachers and students. The organisers foster these interactions

by organising case discussions and workshops in small groups. During the coffee breaks, at lunch and dinner the

teachers mix with the students, so that it is always easy to have in-depth discussions, make new friends and build

networks. The organisers and teachers created a safe and pleasant learning atmosphere. Ingrid Lundberg, head of

the organising committee and moderator of the course, actively involved the students and guided the discussions

upon the need of the participants. In addition to Ingrid’s dedication, the perfect organisational work by Gabriela Kluge

from the EULAR Secretariat and the MCI group merit special thanks: They brought together the international group of

teachers and students in Prague, one of Europe’s historical centers of science and education.

Christian Beyer, EMEUNET Working Group member, Germany

MAY-JUNE16

http://www.eular.org/edu_course_postgraduate.cfm


Ursprungsform

im Menü über:


MORE ON EDUCATION

PAGE 28

THE EMEUNET CALENDAR

We have recently set up a new calendar of events and deadlines that can be found on the

EMEUNET website http://emeunet.eular.org/calendar.cfm

This calendar offers the great opportunity to be synchronized with your own agenda, so that you

will never miss a deadline!

You can use applications such as outlook, using the following ICAL links:

For deadlines: ICS file deadlines

For events: ICS file events

Following the links, you will download a .ics file, if you have outlook installed the calendar should

be automatically added to your agenda when opening the file.

If you have an android phone, the calendar will be automatically available on your phone.

If you have an iPhone, you can easily set it to automatically synchronize with a google account, by

following the instructions at this link

http://www.digitaltrends.com/mobile/sync-multiple-google-calendars-on-iphone-or-ipad

We hope you will find this service useful and we welcome your feedback, should anything go

wrong with the synchronization or should you have any suggestions.

Your EMEUNET Education and Social Media Subgroups

MAY-JUNE16

Young investigators of EMEUNET are from now on an integral part of all task forces and

committees working on new EULAR recommendations. This is a wonderful chance for

EMEUNET to increase its visibility and for you to accelerate your academic career.

Last call came from the EULAR study group for the new EULAR recommendations for the

management of foot and ankle conditions in people with rheumatoid arthritis.

Take a look at emails from EMEUNET and find the opportunity most suitable for you!

JOIN THE TASK FORCES AND COMMITTEES

http://emeunet.eular.org/calendar.cfm

http://tinyurl.com/z5sy9lb

http://tinyurl.com/hbfo4mx

http://www.digitaltrends.com/mobile/sync-multiple-google-calendars-on-iphone-or-ipad


Ursprungsform

im Menü über:


MORE ON EDUCATION

PAGE 29

SESSION PROPOSALS FOR EULAR 2017

EMEUNET Working Group members have the chance to submit their ideas for the Young

Rheumatologist Sessions at EULAR 2017.

Session proposals will be discussed within EULAR scientific committee and if your session

proposal is accepted, you will also be suggested as the session Chair at EULAR. This could be an

exciting opportunity to chair a session! Last year, eight proposals were accepted. You will have the

chance to enjoy these sessions in London.

If you would like to join the EMEUNET WG and be actively involved in such activities keep an eye

on emails from EMEUNET and do not miss next Call for application!

MAY-JUNE16

More information about EMEUNET can be found

in http://emeunet.eular.org

You can also reach us through the following

email [email protected]

www.facebook.com/EMEUNET

www.twitter.com/EMEUNET

educational events - emeunet 2016...eular 2016 see you in london! russka shumnalieva, richard...

Documents